Exagen Group is passionate about renewable energy and its role in driving down greenhouse gas emissions.
Exagen Group has raised $41.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.
Exagen Group's investors include Octopus Energy Group.
Exagen Group is headquartered in London, United Kingdom.
Exagen Group is passionate about renewable energy and its role in driving down greenhouse gas emissions.
Exagen Group is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Exagen Group — Funding & Investors." VCBacked, August 24, 2022, https://www.vcbacked.co/company/exagen-group. Accessed August 14, 2026.
VCBacked. (2022). Exagen Group — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/exagen-group
{{cite web |title=Exagen Group — Funding & Investors |url=https://www.vcbacked.co/company/exagen-group |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated